GlassScriptPhysician profile
Swarna A Lam
NPI 1821541665
$1,821.44
in general payments reported to CMS, 2019-2025
16 companies · $521 in 2025
The $521 reported for 2025 was more than what 75% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $122 · 2023: $687 · 2024: $491 · 2025: $521.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,699.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,699.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $352.85 | 2021-2025 | Epclusa, Vemlidy |
| Amgen INC. | $221.81 | 2024 | Evenity |
| Genzyme Corporation | $218.31 | 2023-2024 | |
| Abbott Laboratories | $174.05 | 2023-2025 | Proclaim, Freestyle Libre 3 |
| Csl Behring | $124.64 | 2024 | Hizentra |
| Novo Nordisk INC | $124.57 | 2023-2025 | Ozempic, Saxenda, Wegovy |
| Viiv Healthcare Company | $121.87 | 2025 | Apretude |
| Corcept Therapeutics | $113.35 | 2025 | Korlym |
| Inspire Medical Systems, INC. | $94.69 | 2023 | Inspire |
| Mylan Specialty L.P. | $85.09 | 2023 | Yupelri |
| Coloplast Corp | $63.32 | 2023 | Altis, Titan |
| Lilly USA, LLC | $41.85 | 2023 | Mounjaro, Trulicity |
| Exact Sciences Corporation | $28.18 | 2023-2024 | Cologuard Collection Kit |
| Organon LLC | $20.92 | 2025 | Nexplanon |
| Hologic Sales and Service, LLC | $19.82 | 2024 | Thinprep 2000 Processor, Aptima |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $16.12 | 2023 | Farxiga |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Swarna Lam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.